
    
      A Phase IIa prospective, open-label, multicenter study to determine the pharmacokinetics (PK)
      and safety and tolerability of aztreonam-avibactam (ATM-AVI) for the treatment of complicated
      Intra-Abdominal Infections (cIAIs) in hospitalized adults.
    
  